DossierENTITY

CAR-T

Coverage of CAR-T in the Nexus archive.

Earliest in view: May 14 · 14:14 UTCMost recent: May 14 · 14:14 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHMay 14 · 14:14 UTCSTAT NEWS
STAT+: BeOne wins FDA approval in lymphoma race
BeOne wins FDA approval in lymphoma race, while Biotech's cell therapy boom expands beyond cancer and CREATE Medicines raises $122 million to advance its in vivo CAR-T for autoimmune disease. The Trump administration is searching for a new FDA commissioner. BeOne's approval marks a significant development in the treatment of lymphoma.